Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 14,607 | 17,265 | 11,434 | 7,649 | 7,969 |
| Operating Income | -14,607 | -17,265 | -11,434 | -7,649 | -7,969 |
| Other Income | -3,221 | 26 | 29 | -473 | 1,600 |
| Pre-tax Income | -17,828 | -17,240 | -11,405 | -8,123 | -6,369 |
| Net Income Continuous | -17,828 | -17,240 | -11,405 | -8,123 | -6,369 |
| Net Income | $-17,828 | $-17,240 | $-11,405 | $-8,123 | $-6,369 |
| EPS Basic Total Ops | -29.54 | -30.43 | -82.46 | -164.47 | -388.76 |
| EPS Basic Continuous Ops | -23.63 | -30.42 | -41.12 | -124.90 | -388.97 |
| EPS Diluted Total Ops | -29.54 | -30.43 | -82.46 | -164.47 | -388.76 |
| EPS Diluted Continuous Ops | -23.63 | -30.42 | -41.12 | -124.90 | -388.97 |
| EPS Diluted Before Non-Recurring Items | -29.54 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-14,560 | $-17,213 | $-11,390 | $-7,520 | $-7,665 |